Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 |
|---|---|---|
| Net Income | -$30.10K | $55.00 |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
